Cited by 498Cannabis and Cannabinoid ResearchAdenosine and Purinergic SignalingInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression

Open access

Carrier, Erica J., Auchampach, John A., Hillard, Cecilia J.·2006·Proceedings of the National Academy of Sciences

Open this paper in CoChat — free account Open PDF

Abstract

The plant-derived cannabinoids delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) both have immunosuppressive effects; although some effects of THC are mediated by the CB2 receptor, CB2 binds CBD weakly. In examining the effects of THC and CBD on microglial proliferation, we found that these compounds potently inhibit [3H]thymidine incorporation into a murine microglial cell line with no effect on cell cycle. Treatment with THC and CBD decreased [3H]thymidine uptake into microglia, with IC50 values that match inhibition of [3H]thymidine incorporation into DNA. CBD and, less potently, THC decreased uptake of [3H]adenosine to a similar extent as [3H]thymidine in both murine microglia and RAW264.7 macrophages. Binding studies confirm that CBD binds to the equilibrative nucleoside transporter 1 with a Ki < 250 nM. Because adenosine agonists have antiinflammatory effects, and because uptake of adenosine is a primary mechanism of terminating adenosine signaling, we tested the hypothesis that CBD is immunosuppressive because it enhances endogenous adenosine signaling. In vivo treatment with a low dose of CBD decreases TNFalpha production in lipopolysaccharide-treated mice; this effect is reversed with an A2A adenosine receptor antagonist and abolished in A2A receptor knockout mice. These studies demonstrate that CBD has the ability to enhance adenosine signaling through inhibition of uptake and provide a non-cannabinoid receptor mechanism by which CBD can decrease inflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0511232103

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Reactive microgliosis
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 900
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 546
The cannabinoid system and immune modulation
Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 533
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530

Show all 39 references

Research works printed but not linked: 7

R. K. Razdan Pharmacol. Rev 38, 75–149 (1986).
R. G. Pertwee Cannabinoids, ed V. Di Marzo (Kluwer Academic/Plenum Publishers, New York), pp. 32–83 (2004).
A. C. Howlett, J. M. Qualy, L. L. Khachatrian Mol. Pharmacol 29, 307–313 (1986).
B. Desoize, C. Leger, J. C. Jardillier, G. Nahas Adv. Biosci 22–23, 145–159 (1978).
B. Desoize, C. Leger, G. Nahas C. R. Hebd. Seances Acad. Sci. D 287, 1441–1444 (1978).
P. G. Smith, H. D. Thomas, H. C. Barlow, R. J. Griffin, B. T. Golding, H. Calvert, D. R. Newell, N. J. Curtin Clin. Cancer Res 7, 2105–2113 (2001).
A. S. Gordon, L. Nagy, D. Mochly-Rosen, I. Diamond Biochem. Soc. Symp 56, 117–136 (1990).

Sorted by citations

Items 401–498 of 498

Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors
Abood, M. E., Sorensen, R. G., & Stella, N. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_12 · Cited by 2
PHARMACOLOGY OF NOVAL CANNABINOIDS
SUMITHA, S. K., PATTAMMADY, V. S., & Ramanathan, S. (2019) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2020v12i1.36005 · Cited by 2
Medical Marijuana for Chronic Pain
Hall, B. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-47117-0_14 · Cited by 2
Preventive Strategies for Chemotherapy-Induced Peripheral Neuropathy
Nielsen, S. W., & Herrstedt, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-78663-2_4 · Cited by 2
Innate Immunity in Viral Encephalitis
Reiss, C. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-33189-8_8 · Cited by 3
Flavonoids and Related Compounds as Nucleoside Transporter Inhibitors
Pimple, S. R. (2008) · doi:10.21007/etd.cghs.2008.0245 · Cited by 2
ToxPoint: The case for Equilibrative Nucleoside Transporters in current regulatory guidance
Martinez-Guerrero, L., Tang, X., Ekins, S., Wright, S. H., & Cherrington, N. J. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf122 · Cited by 1
Modulation of Multispecific Transporters by Uncaria tomentosa Extract and Its Major Phytoconstituents
Szilvásy, N., Lajer, P., Horváth, A., Veres, K., Hohmann, J., Schelz, Z., Minorics, R., Zupkó, I., Gáborik, Z., Kis, E., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111363 · Cited by 1
Empfehlungen der DGRh-Kommission für Komplementäre Heilverfahren und Ernährung zur Anwendung von ausgewählten Phytotherapeutika und pflanzlichen Präparaten in der Rheumatologie
Keyßer, G., Seifert, O., Frohne, I., Michalsen, A., Pfeil, A., Reuss-Borst, M. A., & Sander, O. (2025) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-024-01612-w · Cited by 1
Cannabidiol Pretreatment Reduces Status Epilepticus and Glutamate Uptake Induced by Kainic Acid in Adult Zebrafish
Pickler, K. D. P., de Farias, A. C. S., Lodetti, G., Bernardo, H. T., Baldin, S. L., Dondossola, E. R., Hallak, J. E. C., Crippa, J. A. S., Cararo, J. H., Budni, J., et al. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0189 · Cited by 1
Chronic cannabidiol treatment effects on contextual fear and neuropathic pain in Carioca rats high and low conditioned freezing
Macêdo-Souza, C., Tiballi, A. A. F., Maisonnette, S. S., Rosseti, F. P., Catalão, C. H. R., Hallak, J. E. C., Crippa, J. A. S., Zuardi, A. W., Landeira-Fernández, J., & Leite‐Panissi, C. R. A. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115855 · Cited by 1
The neuroprotective effect of cannabidiol is enhanced by resveratrol and alpha-lipoic acid in social isolation
Ricciardi, F., Morace, A. M., Limongelli, R., Iannotta, M., Boccella, S., Fusco, A., Bonsale, R., Perrone, M., Infantino, R., Martino, E. D., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1676421 · Cited by 1
Phytocannabinoids as anti-inflammatory agents: Synergistic effects when combined with Cannabis sativa L. matrices
Strnad, O., Nejedlý, T., Svoboda, P., Mertlíková‐Kaiserová, H., Malý, M., Malý, M., Stranska-Zachariasova, M., & Viktorová, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121134 · Cited by 1
Phytocannabinoids in Central Nervous System Disorders and Frameworks for Cellular Stress Adaptation: A Comprehensive Review
Lee, H., & Chae, H. (2026) · Innovations in Acupuncture and Medicine · doi:10.1186/s44424-026-00052-4 · Cited by 1
Cannabidiol-Induced Tumor Cell Death: Molecular Mechanisms and Translational Perspectives in Cancer Therapy
Wang, C.-Y., Tan, J.-X., Chen, L., Li, Q., Liu, J., He, X., Qin, Q.-Z., Deng, T., Ruan, G., & Gong, Y. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s597740 · Cited by 1
Cannabidiol and epilepsy: therapeutic, mechanistic and clinical significance
Gupta, N., Maan, P., Shrivastava, J., & Ansari, M. H. R. (2026) · Seizure · doi:10.1016/j.seizure.2026.06.014 · Cited by 2
Differential Effects of Cannabidiol and Cannabigerol on Cognition, Neuroinflammation, and Blood–Brain Barrier Integrity in a Rat Model of Iron Overload
Kowalski, L., Colucci, A. C. M., dos Santos, J. B., Vuaden, B. C. W., Herlinger, A. L., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., de Lima, M. N. M., & Schröder, N. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00826-x · Cited by 1
Immunotoxicology of Drugs of Abuse
Kaplan, B. L. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64180-6 · Cited by 1
Antihypercholesterolemic effects of Hemp (Cannabis sativa)
Kaushal, N., Kaur, R., Garg, A., Sharma, T., & Mehmood, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00044-2 · Cited by 1
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma
Lakshmi, P. K., Pawar, R. S., Katare, Y. K., & Sudheesh, M. S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00583 · Cited by 1
New insights into the crosstalk between endocannabinoids and sphingosine-1-phosphate
Rapino, C., Standoli, S., Cencetti, F., Bruni, P., Oddi, S., & Maccarrone, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110781 · Cited by 1
Therapeutic potential of cannabidiol and its underlying mechanisms
Watanabe, M., Hayasaki, H., Yurugi, Y., & Watanabe, K. (2018) · Journal of allied health sciences · doi:10.15563/jalliedhealthsci.9.112 · Cited by 1
Opioid and Non-opioid Therapy
Maher, D. P., Shah, B. J., & Vorobeychik, Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-27447-4_19 · Cited by 1
Adenosine Metabolism
Hubbard, J. A., & Binder, D. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802401-0.00010-7 · Cited by 1
Cannabis (Marijuana) and Cannabinoids
Upton, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00061-3 · Cited by 2
Medicinal Cannabis for Alzheimer's Disease
Steiner, G. Z., Coles, M., Jaye, K. M., Metri, N., Butt, A. S., Christofides, K., McPartland, J., Al-Modhefer, Z., Karamacoska, D., Russo, E. B., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch001 · Cited by 1
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1
Neurotoxicity and neuroprotection induced by plant-derived cannabinoids
Silva, M. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00071-3 · Cited by 1
Brief: Cannabinoid-Arzneimittel und die Notwendigkeit wissenschaftlicher Methoden
Russo, E. B. (2007) · Cited by 1
Letter: Cannabinoid medicines and the need for the scientific method
Russo, E. B. (2007) · Cited by 1
I Seven International Medical and Nursing Congress
Coelho, P., Rodrigues, F., & Gouveia, A. (2022) · doi:10.56238/sevenmedicalnursing2022 · Cited by 1
Pharmacological actions and associated therapeutic levels of phytocannabinoids Addendum 2021
Arnold, J. C., Allsop, D., Lintzeris, N., & McGregor, I. S. (2016) · doi:10.57022/ovds2305 · Cited by 1
Cannabinoids suppress dendritic cell-induced T helper cell polarization
Lu, T. (2006) · Digital Commons - University of South Florida (University of South Florida)
Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system
Touriño, C. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Efeitos do canabidiol, um canabinóide derivado da Cannabis sativa, em um modelo murino de inflamação pulmonar aguda: uma avaliação imune-neuro-endocrinológica
Ribeiro, A. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2012.tde-01102012-162516
Carta: Los medicamentos cannabinoides y la necesidad del método científico
Russo, E. B. (2007)
Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA
Gomes, F. V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-05012016-224242
Novel cannabidiol and anandamide analogs
D'Souza, M. R. (2012) · Digital Repository Service (Northeastern University) · doi:10.17760/d20002665
Avaliação dos níveis de citocinas em soro e o papel do tratamento com canabidiol em modelo animal de asma
Vuolo, F. S. (2013) · Americanae (AECID Library)
Substance Use and the Systemic Inflammatory Response Syndrome (SIRS) Following Trauma
NeSmith, E. G., Weinrich, S., Andrews, J. O., Medeiros, R. S., Hawkins, M. L., Weinrich, M. C., & Jones, R. (2011) · Journal of Trauma Nursing · doi:10.1097/jtn.0b013e31821f1ec9
The acute cognitive, psychological and electrophysiological effects of cannabis constituents
Englund, A. (2015)
Subjecffve effects of cannabidiol in anxiety disorder and canabinoid excretion in chronic daily cannabis smokers during sustained abstinence
Bergamaschi, M. M. (2012) · doi:10.11606/t.60.2012.tde-11012013-102122
Envolvimento do núcleo leito da estria terminal nos efeitos ansiolíticos do canabidiol
Gomes, F. V. (2011) · doi:10.11606/d.17.2011.tde-17062015-122906
Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.018
Cannabinoids: Chemistry and Medicine 112
Appendino, G., & Taglialatela‐Scafati, O. (2013)
Residual Effects of Cannabis on Young Drivers' Performance of Driving-Related Skills: An Interim Analysis
Pan, J. (2016) · TSpace (University of Toronto)
Innate immunity in viral encephalitis
Reiss, C. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.019
The effect of purine nucleoside, analogues, ribavirin and tiazofurin, on microglial activation under inflammatory conditions
Savić, D. Z. (2012) · doi:10.2298/bg20121001savic
Microglia and astrocytoma cells express alkylindole-sensitive receptors
Fung, S. (2014) · ResearchWorks at the University of Washington (University of Washington)
Neuroimmunopharmacology at the Interface of Inflammation and Pharmacology Relevant to Depression
Holmes, J., Corrigan, F., & Hutchinson, M. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00012-x
Rapamycin-based macrocyclic library development and Equilibrative Nucleoside Transporter 1 (ENT1) inhibition
Hong, S. Y. (2016)
Mecanismos envolvidos no perfil antipsicótico do canabidiol
Pedrazzi, J. F. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-30042019-163956
EFFECTS OF CANNABIDIOL ON VOCAL LEARNING AND RECOVERY FROM CNS DAMAGE
Alalawi, A. M. (2019) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Cannabinoids in Neurologic Conditions
Gaston, T. E., Szaflarski, J. P., Bowling, A. C., Liu, Y., Seawalt, T., Leehey, M. A., Nelson, E. L., Rajpal, S., Villavicencio, A. T., Bauer, A. M., et al. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_10
Efeitos neuroprotetores do canabidiol em modelo experimental de hemorragia da matriz germinativa
Almeida, T. (2019) · doi:10.11606/t.17.2019.tde-01062020-074843
The Not-So-Perfect Remedy
Doleys, D. M., & Doleys, N. D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780197544631.003.0019
Avaliação das possíveis interações entre o canabidiol e a ayahuasca em voluntários saudáveis: um estudo randomizado, duplo-cego e controlado com placebo
Rossi, G. N. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-08022021-150020
Behavioural and molecular effects induced by Cannabidiol in animal models of depression
Silote, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2021.tde-29092021-060118
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1818-8_18
Faculty Opinions recommendation of Cannabinoids in the treatment of epilepsy: hard evidence at last?
Pack, A. M., & Sekar, K. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732529679.793556778
Canabidiol em modelo pré-clínico de dor neuropática: uma avaliação dos aspectos sensoriais, emocionais e inflamatórios relacionados com a modulação da sensibilidade dolorosa
Cardoso, G. K. R. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2022.tde-01092022-134636
Application of cannabidol to ocular pharmacokinetics and pharmacodynamics.
Laun, A. S. (2022) · doi:10.18297/etd/3952
Avaliação dos efeitos do canabidiol sobre as consequências comportamentais induzidas pelo tratamento com o ácido valproico durante o período embrionário do zebrafish
Costa, K. C. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-05062023-141905
A kannabidiol és az adenozinerg rendszer kapcsolata
Viczján, G., Óvári, I., & Erdei, T. (2023) · Egészségügyi Innovációs Szemle · doi:10.56626/egis.v2i2.12972
Efectos terapéuticos del Cannabidiol en la epilepsia: un estudio preclínico en el modelo animal de epilepsia audiogénica GASH/Sal
Cabral-Pereira, G. (2023) · Gredos (University of Salamanca) · doi:10.14201/gredos.153215
Effects of cannabidiol on metabolic modulation and improving sports performance: a systematic review
Conter, F. D. S., Ishikawa, V. N., Gontijo, G. M., Ichikawa, A. I. T., & Bubna, P. (2023) · International Journal of Nutrology · doi:10.54448/ijn23401
Tratamento sistêmico com canabidiol em ratos das linhagens Cariocas de alto e baixo congelamento no modelo de dor crônica: avaliação da dor, da ansiedade e da expressão de BDNF em áreas encefálicas
de Souza, C. M. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2023.tde-01122023-152146
Tratamento com canabidiol em modelo de inflamação persistente em camundongos: avaliação dos componentes quantitativos e qualitativos da dor
Petrilli, L. A. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2023.tde-07022024-170356
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Immunotoxicology of Drugs of Abuse
Kaplan, B. L. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00051-6
Differential Learned Helplessness Phenotypes in Male and Female Rats: Exploring the Therapeutic Impact of Cannabidiol TreatmentPreprint
Akirav, I., & Bright, U. (2024) · Research Square · doi:10.21203/rs.3.rs-4270261/v1
Characterisation of Components of an Extract of Hemp and Preliminary Assessment of Anti-Inflammatory Activity in an Ex Vivo Model of Bovine EndometritisPreprint
Nash, D. M., Parveen, I., Allen, N. R., Wonfor, R. E., Al-Fadhli, A. A., Giles, J. L., Walton, R. T., & Threadgill, M. D. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4838423
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141
Topical use of cannabis oil for wound healing in a dog
Mariga, C., Teixeira, B. A., & Filho, S. T. L. P. (2024) · ACTA SCIENTIAE VETERINARIAE · doi:10.22456/1679-9216.138424
The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro
Alexander, S. P. H. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_605
Microvascular Effects of Cannabinoids
Tuma, R. F., Li, H., Reichenbach, Z. W., Ward, S. J., & Elliott, M. B. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_12
Therapeutic Potential of Cannabidiol in Dentistry: A Systematic Review From Cellular Mechanisms to Clinical Trials
Kornsuthisopon, C., Chansaenroj, A., Vimolmangkang, S., Samaranayake, L. P., & Osathanon, T. (2025) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.70081
The Pharmacokinetic and Pharmacodynamic Drug-drug Interaction Potential of Cannabidiol
Keller, G. A., & Aimar, J. A. (2025) · Drug Metabolism and Bioanalysis · doi:10.2174/0118723128411684251029100517
Cannabidiol does not cause DNA double-strand breaks in a human liver-derived cell model
Weiss, R., Liedtke, V., & Rödiger, S. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00365-w
FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast
Boury‐Esnault, N., Marschal, C., Probst, J.-M. K., & Barnathan, G. (2002) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.155630
Anti-seizure potential of J4, an equilibrative nucleoside transporter 1 inhibitor, in a mouse model of tuberous sclerosis complex in response to pentylenetetrazol
Hsieh, C. C., Huang, N., Tung, S.-Y., Lin, W.-X., Wang, H., Nguyen, T. T. A., Chern, Y., & Lee, Y. (2026) · Cell & Bioscience · doi:10.1186/s13578-025-01518-3
Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma
Chávez-López, M. D. G., Ávalos‐Fuentes, A., Cruz-Manzo, E. D. C., Aguirre-Arriaga, P. A., Florán, B., Pérez‐Carreón, J. I., Bañuelos, C., & Camacho, J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33010008
Sex and dose-dependent effects of cannabidiol on cocaine consumption in mice
Llerena, V., Tic, I., Llach-Folcrà, M., Valverde, O., & Medrano, M. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03880-3
Mechanistic Pathways Linking Cannabidiol, Hemp Seed Oil and Black Sesame Oil in Hyperarousal Insomnia: A Narrative Review
Kovitkanit, P., & Kamoltham, T. (2026) · Clocks & Sleep · doi:10.3390/clockssleep8020016
Diathermic Evaluation of Sustained Acoustic Medicine with Cannabidiol Coupling Gel
Bates, E., Cress, M., Paul, R., & Sampson, S. (2026) · Applied Sciences · doi:10.3390/app16094544
Anxiolytic and sedative drugs: Sleep modulation and memory implications
Marcoccia, S., Chiacchierini, G., & Campolongo, P. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111793
Probe-Based Chemical Proteomics Identifies UDP-Glucose 6-Dehydrogenase as a Potential Cannabidiol-Interacting Protein
Wang, X., Chu, F.-X., Zhou, S., Chen, B., Zou, S., Fei, Q., Ren, R., Su, M., & Di, B. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00586
Calcium signaling in human and mouse microglia exhibit differential susceptibility to phytocannabinoids
Pilchová, I., Fleig, A., & Penner, R. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03031-7
Canabidiol medicinal: percepção dos dentistas e graduandos de odontologia
Henriques, M. F. L., Castro, B. C. D. C. C. E., CUNHA, M. E. G., & Lopes, M. D. F. (2026) · Revista de Odontologia da UNESP · doi:10.1590/1807-2577.20250049
Überblick über medizinisches Cannabis
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_4
Interactions of ACEA and WIN 55,212-2 mesylate with temozolomide and cisplatin in neuroblastoma and glioblastoma cell lines: an isobolographic analysis
Załuska-Ogryzek, K., Wróblewska-Łuczka, P., Góralczyk, A., Chojnacki, M., & Łuszczki, J. J. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00898-8
Phytocannabinoid cannabidiol (CBD) in neurodegenerative diseases: From polypharmacology to drug development
Zhang, B., Nan, J., Zhang, Y., Zhang, B., Ke, C., Wang, W., Wu, T., Xia, J., Yang, F., He, M., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119360
Reimagining Cannabidiol Delivery Through Carbon Nanodots
Ibrahim, I., Lawrence, K., Forte, O. A., Naidu, N. C., Huitt, L., Ajibola, N., Xu, J., Boakai, R. K., Mengu, M., Akabanda, F., et al. (2026) · Molecules · doi:10.3390/molecules31193404
Cannabis THC:CBD Composition Affects Oligodendrocyte Progenitor Cell Characteristics Following Acute Cannabis Vapor Inhalation in Adult Male and Female MicePreprint
Murray, C. J., Thorpe, H. H. A., Kayır, H., Osborne, E., Foster, S. W., Loewen, S. M., Rogers, M., Vecchiarelli, H. A., Khokhar, J. Y., & Tremblay, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.18.752658
Investigação do possível envolvimento de receptores adenosinérgicos nos efeitos comportamentais induzidos pelo canabidiol em camundongos submetidos a diferentes modelos animais
da Silveira, J. R. F. (2021) · doi:10.11606/003107309
Cannabidiol for chronic neuroinflammation: clinical pharmacology and what an interpretable trial will requirePreprint
Soderstrom, K., & Litwa, K. (2026) · doi:10.22541/authorea.15009897/v1
Cannabidiol in Alzheimer’s disease: evidence-weighted molecular mechanisms and translational challenges
Sura, S., Jagadeesan, S., Masrudin, S. S., Moklas, M. A. M., & Nor, N. H. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-13034-9
BindingDB Entry 50045494: Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
BindingDB (2016) · UC San Diego · doi:10.7270/q2z60qrx

Authors: Carrier, E. J., Auchampach, J. A., & Hillard, C. J.
Affiliations: Medical College of Wisconsin (US)
ORCID: Carrier, Erica J.
Auchampach, John A.
Hillard, Cecilia J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2006-05-16
Volume: 103
Issue: 20
Pages: 7895-7900
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0511232103
OpenAlex: W2067960394
Cited by: 497
References: 39
Citations by year: 2026: 20 · 2025: 30 · 2024: 29 · 2023: 33 · 2022: 40 · 2021: 33 · 2020: 40 · 2019: 32 · 2018: 19 · 2017: 25 · 2016: 20 · 2015: 19 · 2014: 11 · 2013: 20 · 2012: 24
FWCI: 14.00
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (HL 077707, R01HL077707)
National Institute on Drug Abuse (R01DA009155, DA 16967, DA09155, R01DA016967)
National Institute of Neurological Disorders and Stroke (NS041314, R01NS041314)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords: cannabidiol, delta-9-tetrahydrocannabinol, equilibrative nucleoside transporter 1, adenosine uptake, adenosine signaling, adenosine A2A receptor, microglial proliferation, macrophages, TNF-α, lipopolysaccharide-induced inflammation, anti-inflammatory activity
MeSH terms: Rimonabant, Adenosine, Animals, Camphanes, Cannabidiol, Cell Line, DNA, Immunosuppression Therapy, Lipopolysaccharides, Male, Mice, Inbred C57BL, Piperidines, Psychotropic Drugs, Pyrazoles, Dronabinol, Thymidine, Tumor Necrosis Factor-alpha, Microglia, Nucleoside Transport Proteins, Equilibrative Nucleoside Transporter 1, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks